Management of Immune Checkpoint Inhibitor Mediated Myocarditis

被引：0
|
作者：
Mudra, Sarah
Culver, Austin
Kumar, Ashwin
Yesilyaprak, Abdullah
Agrawal, Ankit
Dey, Amit K.
Rizk, Alexander
Li, Jason
Johnson, Adam
McGowan, Kevin
Majid, Muhammad
Njus, Meredith
Lawrence, Luke
Klein, Allan L.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cardio-oncology;
D O I：
10.1161/circ.148.suppl_1.18997
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18997
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Smoldering myocarditis following immune checkpoint blockade
    Norwood, Timothy G.
    Westbrook, Brian C.
    Johnson, Douglas B.
    Litovsky, Silvio H.
    Terry, Nina L.
    Mckee, Svetlana B.
    Gertler, Alan S.
    Moslehi, Javid J.
    Conry, Robert M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [22] Non-Bacterial Thrombotic Endocarditis and Recurrent Cerebrovascular Accidents in Immune Checkpoint Inhibitor Myocarditis
    Mitrani, Lindsey
    Jou, Stephanie
    Mendez, Sean
    Song, Christopher
    Yoon, Joseph
    Dangayach, Neha S.
    Sahni, Gagan
    CIRCULATION, 2023, 148
  • [23] Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis
    Nishikawa, Tatsuya
    Kunimasa, Kei
    Ohta-Ogo, Keiko
    Ikeda, Yoshihiko
    Yasui, Taku
    Shioyama, Wataru
    Oka, Toru
    Honma, Keiichiro
    Hatakeyama, Kinta
    Kumagai, Toru
    Fujita, Masashi
    INTERNAL MEDICINE, 2022, 61 (14) : 2161 - 2165
  • [24] TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis
    Liu, Xiaohang
    Wu, Wei
    Fang, Ligang
    Liu, Yingxian
    Chen, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
    Jesus Jimenez
    Nicolas Kostelecky
    Joshua D. Mitchell
    Kathleen W. Zhang
    Chieh-Yu Lin
    Daniel J. Lenihan
    Kory J. Lavine
    Cardio-Oncology, 9
  • [26] Relevance of surveillance manual for the early detection of immune checkpoint inhibitor-induced myocarditis: A case series
    Oyakawa, Takuya
    Muraoka, Nao
    Iida, Kei
    Fujita, Ayano
    Yokoyama, Koichi
    Ishikawa, Hiroshi
    Murakami, Haruyasu
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2024, 11 (11)
  • [27] Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
    Jimenez, Jesus
    Kostelecky, Nicolas
    Mitchell, Joshua D. D.
    Zhang, Kathleen W. W.
    Lin, Chieh-Yu
    Lenihan, Daniel J. J.
    Lavine, Kory J. J.
    CARDIO-ONCOLOGY, 2023, 9 (01)
  • [28] Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis-Same or Different?
    Zornitzki, Lior
    Havakuk, Ofer
    Rozenbaum, Zach
    Viskin, Dana
    Arbel, Yaron
    Flint, Nir
    Arnold, Joshua
    Waissengein, Barliz
    Wolf, Ido
    Banai, Shmuel
    Topilsky, Yan
    Laufer-Perl, Michal
    LIFE-BASEL, 2022, 12 (09):
  • [29] Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature
    Nakagomi, Yuki
    Tajiri, Kazuko
    Shimada, Saori
    Li, Siqi
    Inoue, Keiko
    Murakata, Yoshiko
    Murata, Momoko
    Sakai, Shunsuke
    Sato, Kimi
    Ieda, Masaki
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Myocarditis in Patients With Cancer Undergoing Combination Checkpoint Inhibitor Therapy
    Lindsay, Alistair C.
    Walker, Alexander N.
    Schneeweiss, Sebastian
    CIRCULATION, 2023, 148
12345